Müllerian Agenesis — Mayer-Rokitansky-Küster-Hauser Syndrome

The embryology, and why only some structures are lost

• Every embryo forms two duct systems: the paramesonephric (Müllerian) ducts and the mesonephric (Wolffian) ducts. In the absence of anti-Müllerian hormone, the Müllerian ducts persist and give rise to the fallopian tubes, uterus, cervix and upper two-thirds of the vagina
• The lower third of the vagina has a separate origin — the urogenital sinus and sinovaginal bulbs — which is why these patients have normal external genitalia and a short blind-ending vaginal pouch rather than no vagina at all
• The ovaries derive from the gonadal ridge, colonized by primordial germ cells migrating from the yolk sac. This is an entirely separate lineage from the Müllerian ducts, which is the single most important physiologic fact in the disease: the ovaries are normal. Estrogen production, the hypothalamic-pituitary-ovarian axis, ovulation, and the oocyte pool are all intact
• Failure of Müllerian duct development, canalization or caudal fusion therefore removes the uterus and upper vagina while leaving the endocrine system, the external genitalia and the germ cells untouched
• Fallopian tubes are usually present, since the upper duct segments often develop; the uterus is typically represented by bilateral rudimentary muscular buds connected by a peritoneal band

Why the ducts fail

• Most cases are sporadic, with no identified cause. Familial clustering exists and suggests autosomal dominant inheritance with incomplete penetrance and variable expressivity in a minority of families
• Implicated loci include WNT4, HNF1B, LHX1, TBX6 and recurrent 16p11.2 deletions. WNT4 mutations produce a distinct variant: Müllerian aplasia with clinical and biochemical hyperandrogenism, which is not classic MRKH and should be recognized as separate
• The shared embryologic origin of the Müllerian ducts and the mesonephric (renal) system — the ducts develop alongside and depend on the mesonephros — explains the strong association with renal anomalies. The nearby developing somites explain the vertebral associations

Why a minority have pain

• Roughly 2-7% have a rudimentary uterine horn containing functional endometrium. That endometrium responds to normal ovarian cycling but has no outflow tract, producing cyclic pelvic pain, hematometra, and retrograde menstruation with secondary endometriosis
• The remainder, with no functional endometrium, are entirely painless — which is why MRKH classically presents as painless primary amenorrhea and obstructive anomalies present as painful primary amenorrhea

Classification

• Type I (typical, isolated) — approximately 45-55% of cases. Symmetric uterovaginal aplasia with normally positioned fallopian tubes and no extragenital anomalies
• Type II (atypical) — asymmetric uterine buds, tubal anomalies, or ovarian maldescent, with associated malformations
• MURCS association — the severe end of type II: MÜllerian duct aplasia, Renal agenesis/dysplasia, and Cervicothoracic Somite dysplasia

Associated anomalies — the reason imaging extends beyond the pelvis

• Renal (~30-40%): unilateral renal agenesis is the most common, followed by pelvic or horseshoe kidney, renal ectopia, and duplicated collecting systems. A renal ultrasound is mandatory in every patient
• Skeletal (~10-20%): vertebral segmentation defects, scoliosis, Klippel-Feil anomaly (short neck, low posterior hairline, restricted cervical motion), rib anomalies
• Auditory (~10-25%): conductive or sensorineural hearing loss; audiology screening is reasonable
• Cardiac (~1-5%): septal defects, aortic coarctation, and pulmonary anomalies are described but uncommon
• Ovarian maldescent into a high or inguinal position occurs in a minority and matters for later oocyte retrieval

Risk factors

• No reproducible environmental or teratogenic association has been established. Maternal diabetes and gestational drug exposures have been proposed and not confirmed
• Diethylstilbestrol in utero causes a different problem — T-shaped uterine cavity, cervical hood, clear cell adenocarcinoma of the vagina — and is not a cause of Müllerian agenesis
• A first-degree relative with Müllerian agenesis or unexplained primary amenorrhea raises suspicion but most patients have no family history

The presenting picture

• Primary amenorrhea at age 15-18 in an adolescent who is otherwise entirely well and whose puberty has been normal — this is the whole presentation in the majority
• Normal breast development (Tanner stage IV-V) and normal pubic and axillary hair, because ovarian estrogen and adrenal/ovarian androgens are both normal. The combination of normal breasts and normal pubic hair is the finding that separates MRKH from complete androgen insensitivity at the bedside
• Normal height and growth, in contrast to the short stature of Turner syndrome
• Normal external genitalia — labia, clitoris and introitus are unremarkable on inspection
• A short, blind-ending vaginal pouch, typically 1-3 cm ("vaginal dimple"), found on gentle examination. The cervix is absent
• No palpable uterus on rectoabdominal or bimanual examination
• Absent cyclic symptoms in most: no molimina, no cyclic pain

When it presents differently

• Cyclic pelvic pain with primary amenorrhea in the 2-7% with obstructed functional endometrium in a rudimentary horn — increasing monthly pain, sometimes with a palpable adnexal mass, and later the sequelae of endometriosis
• Apareunia or dyspareunia rather than amenorrhea, when a patient presents in her late teens or twenties after attempting intercourse
• Discovery during evaluation of an unrelated anomaly — a solitary kidney found incidentally, or scoliosis being worked up, prompting pelvic imaging
• Infertility evaluation in patients from settings where menstrual history was never elicited

Physical examination essentials

• Assess Tanner staging of both breasts and pubic hair separately — their dissociation is diagnostic information, not a formality
• Inspect the perineum for a bulging bluish membrane (imperforate hymen) or a normal-appearing introitus with a short pouch (MRKH or a transverse vaginal septum)
• Palpate the inguinal canals for gonads — inguinal or labial masses suggest testes and point to androgen insensitivity, not MRKH
• Look for the cervicothoracic stigmata of MURCS: short neck, low hairline, torticollis, scoliosis
• Examination in an adolescent should be limited, explained in advance, and often deferred to imaging; a vaginal examination is not required to make the diagnosis

Establish the karyotype and the hormonal profile first

• Karyotype: 46,XX — this is the single test that separates MRKH from complete androgen insensitivity and is non-negotiable in any patient with primary amenorrhea and an absent uterus
• Serum testosterone in the normal female range — in complete AIS it is in the normal male range. Together with the karyotype this closes the question
• FSH, LH and estradiol are normal, reflecting intact ovarian function. Elevated FSH points instead to gonadal dysgenesis or primary ovarian insufficiency
• Add prolactin and TSH as part of any primary amenorrhea evaluation, and hCG regardless of the reported history

Imaging

• Pelvic ultrasound is first-line: absent or rudimentary uterus, absent cervix, and normal ovaries — though the ovaries may sit high or ectopically and can be difficult to visualize transabdominally in an adolescent
• Pelvic MRI is the gold standard for characterizing the anatomy before any intervention: it defines uterine remnants, identifies functional endometrium within them (the finding that drives surgical excision), measures vaginal length, locates the ovaries, and detects associated anomalies. It is also the best test to distinguish MRKH from a transverse vaginal septum or cervical agenesis, where an obstructed but present uterus is at stake
• Renal ultrasound in every patient — 30-40% have a renal anomaly, and a solitary kidney changes lifelong management
• Spine imaging where scoliosis or cervicothoracic findings are present; audiometry given the association with hearing loss
• Diagnostic laparoscopy is rarely required now that MRI is available, and should not be used as a primary diagnostic step

The differential that matters

• Complete androgen insensitivity syndrome (CAIS) — 46,XY, testosterone in the male range, absent or sparse pubic and axillary hair, testes intra-abdominally or in the inguinal canals. The uterus is absent because functioning Sertoli cells produced AMH. Gonadectomy is eventually indicated because of germ cell tumor risk; in MRKH the gonads are normal ovaries and must be preserved
• Imperforate hymen — primary amenorrhea with cyclic pain, a bulging bluish membrane at the introitus, and hematocolpos. The uterus is present and the problem is surgical and curable
• Transverse vaginal septum or cervical agenesis — cyclic pain, a present uterus on MRI, no bulging membrane. Distinguishing this from MRKH is critical because these patients have a uterus to preserve
• Gonadal dysgenesis, including Turner syndrome — elevated FSH, absent or delayed breast development, short stature, and a present (streak-associated) uterus
• Asherman syndrome — a cause of secondary, not primary, amenorrhea, following instrumentation or infection
• Functional hypothalamic amenorrhea, PCOS, hyperprolactinemia — all have a present uterus, which is the branch point of the entire algorithm

Counselling comes first, and it is the treatment

• Disclose the diagnosis in unhurried, planned visits with developmentally appropriate language, ideally with a clinician experienced in differences of sex development. This information is rarely absorbed in one sitting
• State explicitly what is intact: the ovaries work, hormones are normal, no hormone replacement is needed, sexual function is achievable, and genetic motherhood is possible. Patients frequently assume the opposite of all four
• Affirm female gender identity and address body image, disclosure to partners, and timing of intervention on the patient's terms
• Refer to psychological support and peer support groups. Depression, anxiety and sexual distress are common and respond to structured support; this is a standard-of-care component, not an optional extra
• Screen and manage the associated renal, skeletal and auditory anomalies; a solitary kidney warrants counselling about nephrotoxins, blood pressure and contact sports

Vaginal creation — dilation first

• Primary vaginal dilation (the Frank technique) is first-line, with success rates of approximately 90-95% in motivated patients. Graduated dilators are applied with pressure to the vaginal dimple for roughly 10-30 minutes once or twice daily over weeks to months
• It requires no surgery, no anesthetic and no graft, and it avoids the complication profile of every operative alternative. It should be offered to essentially every patient before an operation is discussed
• Timing is driven by the patient's readiness and motivation, not by age or by parental preference. A patient who is not ready will not succeed, and a failed premature attempt makes later success harder
• Ongoing dilation or regular intercourse is needed to maintain the neovagina after either dilation or surgery

Surgical vaginoplasty — when dilation fails or is declined

• Vecchietti procedure: laparoscopically placed traction device that invaginates the vaginal dimple over about a week; short, effective, and the most common approach where available
• McIndoe procedure: a split-thickness skin graft over a mold — historically standard, with graft contracture and donor-site morbidity as its limitations
• Davydov procedure: peritoneal pull-through, creating a peritoneum-lined vagina
• Bowel (sigmoid) vaginoplasty: produces a self-lubricating vagina but carries the morbidity of bowel surgery, chronic mucus discharge, and a small long-term malignancy risk
• All surgical routes still require postoperative dilation to prevent stenosis — surgery does not remove that requirement

Managing a functional rudimentary horn

• Laparoscopic excision of an obstructed rudimentary horn containing functional endometrium relieves cyclic pain and limits progressive endometriosis. Hormonal suppression is a temporizing measure, not a solution
• Non-functional remnants require no intervention

Fertility

• The uterus is absent, but the ovaries and oocytes are normal. IVF with oocyte retrieval and a gestational carrier allows genetic motherhood and is the established route. Ectopic or high ovarian position may complicate retrieval and should be mapped on MRI beforehand
• Uterine transplantation has moved from experimental to an available option at specialized centers, with the first live birth reported in 2014 and many since. It requires a donor uterus, immunosuppression through pregnancy, delivery by cesarean, and graft removal afterward; MRKH is the single largest indication
• Adoption should be presented as a parallel option, not a fallback

What not to do

• Do not remove the gonads — they are normal ovaries. This is the sharpest divergence from CAIS management
• Do not prescribe estrogen replacement — the ovaries produce normal estrogen, and bone density and cardiovascular risk are unaffected
• Contraception is unnecessary for pregnancy prevention, but barrier protection against sexually transmitted infection remains relevant once a neovagina is in use

• Psychological morbidity: depression, anxiety, and distress around body image, sexual identity and disclosure. Reported rates are high, and outcomes improve measurably with structured psychological and peer support
• Sexual dysfunction: apareunia before treatment; dyspareunia, inadequate length, or poor lubrication afterward. Satisfaction after both dilation and surgery is generally good but depends heavily on maintenance and on counselling quality
• Neovaginal stenosis and contracture from lapsed dilation after either dilation or vaginoplasty — the most common late failure of every technique
• Graft-specific complications: donor-site morbidity and graft contracture after McIndoe; prolapse of the neovagina; rectovaginal or vesicovaginal fistula; chronic mucus discharge and diversion-type colitis after bowel vaginoplasty; rare malignancy arising in graft or bowel neovaginal tissue on long-term follow-up
• Endometriosis and chronic pelvic pain from retrograde menstruation out of an obstructed functional remnant, with adhesive disease and its own operative morbidity
• Hematometra and hematosalpinx in an obstructed horn, occasionally presenting acutely
• Renal complications in patients with a solitary or ectopic kidney: hypertension, hyperfiltration injury, and the consequences of a single-kidney reserve
• Obstetric complications after uterine transplantation: graft rejection, immunosuppression exposure, preterm delivery, and preeclampsia — managed only in experienced programs
• Diagnostic harm: mistaking MRKH for CAIS and removing normal ovaries, or mistaking cervical agenesis for MRKH and losing a preservable uterus. Both are consequences of skipping the karyotype or the MRI

• Primary amenorrhea + normal breasts + normal pubic hair + absent uterus + 46,XX = Müllerian agenesis. Change "normal pubic hair" to absent or sparse pubic hair with a 46,XY karyotype and testosterone in the male range, and the answer is complete androgen insensitivity
• The ovaries are normal because they come from the gonadal ridge, not the Müllerian ducts. Therefore: normal estrogen, normal puberty, no hormone replacement, no gonadectomy, and genetic motherhood is possible through IVF with a gestational carrier
• MRKH is the second most common cause of primary amenorrhea, after gonadal dysgenesis
• Order a renal ultrasound in every patient — 30-40% have a renal anomaly, most often unilateral renal agenesis
• MURCS = MÜllerian aplasia, Renal anomalies, Cervicothoracic Somite dysplasia
• MRKH is painless; obstruction is painful. Cyclic pelvic pain with primary amenorrhea means an outflow obstruction — a bulging bluish membrane is an imperforate hymen, a normal introitus with a uterus on MRI is a transverse septum or cervical agenesis, and a normal introitus with no uterus is the 2-7% of MRKH with a functional rudimentary horn
• FSH is normal, which excludes gonadal dysgenesis; height is normal, which excludes Turner syndrome
• The lower third of the vagina is present because it derives from the urogenital sinus — hence normal external genitalia with a short blind pouch, not absent genitalia
• Vaginal dilation is first-line, succeeding in roughly 90-95%, and timing is set by the patient's readiness. Surgery is for failure or refusal, and dilation is still required afterward
• Pelvic MRI before any intervention — it finds functional endometrium worth excising and distinguishes MRKH from a preservable obstructed uterus
• WNT4 mutation with hyperandrogenism is a distinct entity, not classic MRKH
• Uterine transplantation is a real option, with MRKH as its leading indication and live births since 2014
• Counselling and psychological support are part of the treatment, not an adjunct to it — the medical anatomy is simple, the disclosure is not